细胞学低风险不确定甲状腺结节的自然史
这项单中心回顾性研究纳入371例初次细针穿刺活检(FNAB)细胞学结果为低风险不确定病变(TIR3A)的甲状腺结节患者,评估其自然史。TIR3A结节恶性率为16.5%,重复FNAB在40%病例中提供更明确诊断并使恶性风险增加5%;保守随访患者在中位3.3年随访期间结节大小和超声模式无显著变化。作者认为,尤其在没有其他危险因素时,主动监测是管理TIR3A结节的安全选择。
要点
- 371例TIR3A结节患者中,102例首次内分泌评估后手术,269例保守随访。
- TIR3A结节恶性率为16.5%,多数干预原因与TIR3A结果无关。
- 保守随访患者在中位3.3年随访期间结节大小和超声模式无显著变化。
核心结论
- 这些发现提示,主动监测是管理TIR3A结节的安全选择,尤其在没有其他危险因素时。
- 该研究强调重复FNAB在减少不必要手术中的作用,并强调TIR3A结节总体惰性的特点。
研究设计与样本
- 单中心回顾性研究,回顾性检索2017年7月至2019年12月期间进行的FNAB,纳入初次细胞学结果为TIR3A的甲状腺结节患者,最终研究组371例。
主要发现
- 371例初始TIR3A细胞学结果患者中,102例在首次内分泌评估后接受手术,269例接受保守随访。
- 269例保守随访患者中120例重复FNAB,其中13例随后接受手术。
- TIR3A结节恶性率为16.5%,多数干预原因与TIR3A结果无关。
- 重复FNAB在40%病例中提供更明确诊断,恶性风险增加5%。
- 保守管理的TIR3A患者(149例未重复FNAB和66例至少重复一次FNAB)在中位3.3年随访期间结节大小和/或超声模式无显著变化。
临床怎么用
- 作者认为,主动监测是管理TIR3A结节的安全选择,尤其在没有其他危险因素时。
- 作者强调重复FNAB在减少不必要手术中的作用,并指出TIR3A结节总体惰性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Thyroid nodules classified cytologically as low-risk indeterminate lesions (TIR3A) on fine-needle aspiration biopsy (FNAB) present a clinical challenge due to their uncertain malignancy risk. OBJECTIVE: This single-center study aimed to evaluate the natural history of TIR3A nodules. METHODS: FNABs performed between July 2017 and December 2019 were retrospectively retrieved and patients, with TIR3A nodules were evaluated at baseline and throughout a follow-up based on ultrasound (US) parameters and clinical data. RESULTS: The final study group encompassed 371 patients with an initial TIR3A cytological result. Among them, 102 were directed to surgery after the first endocrinological evaluation, and 269 were directed to conservative follow-up. Repeat FNAB was performed in 120 out of 269 and 13 further patients underwent surgery following FNAB repetition. The malignancy rate among TIR3A nodules was 16.5%, with most interventions being performed for reasons unrelated to the TIR3A result. Repeat FNAB provided a more definitive diagnosis in 40% of cases, with a 5% increase in malignancy risk. The remaining patients were monitored with clinical and US follow-up. Among all patients with TIR3A cytology managed conservatively (149 without FNAB repetition and 66 with at least one FNAB repetition), no significant changes in nodule size and/or US pattern were observed during a median follow-up of 3.3 years. CONCLUSION: These findings suggest that active surveillance is a safe option for managing TIR3A nodules, particularly when no additional risk factors are present. The study highlights the role of repeat FNAB in reducing unnecessary surgeries and underscores the generally indolent nature of TIR3A nodules.
引用
- Teliti M, Chytiris S, Coperchini F, et al. Natural History of Cytologically Low-Risk Indeterminate Thyroid Nodules. J Clin Endocrinol Metab. 2025. PMID: 39879628. doi:10.1210/clinem/dgaf052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。